Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Do we need other targets for treating angiogenic disorders: novel opportunities with PLGF — Lieve Moons (2003) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Do we need other targets for treating angiogenic disorders: novel opportunities with PLGF
Shared by
Peter Carmeliet
Aarhus University
Do we need other targets for treating angiogenic disorders: novel opportunities with PLGF
Article
2003
en
Authors
+3 more
LM
Lieve Moons
MA
Monica Autiero
SP
Stéphane Plaisance
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2015
Do we need ARDS?
Jean Louis Vincent
,
Carlos A. Santacruz
Article
2002
Do we need placebo control in maintenance studies in bipolar disorders?
Eduard Vieta
Editorial Material
1999
Do we need intermediate care units?
Jean Louis Vincent
,
H. Burchardi
Article
2008
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Christian Fischer
,
Massimiliano Mazzone
,
Bart Jonckx
,
Peter Carmeliet
Article
2009
Coronary angioplasty: do we need to EuroSCORE?
Scot Garg
,
Patrick W. Serruys
Nature Reviews Cardiology
Discussion(0)
No comments yet. Be the first to comment.